247 related articles for article (PubMed ID: 33437055)
21. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
22. CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort.
Spallazzi M; Barocco F; Michelini G; Immovilli P; Taga A; Morelli N; Ruffini L; Caffarra P
Acta Neurol Belg; 2019 Sep; 119(3):445-452. PubMed ID: 30847669
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal Fluid Metals and the Association with Cerebral Small Vessel Disease.
Shams M; Martola J; Charidimou A; Granberg T; Ferreira D; Westman E; Wintermark M; Iv M; Larvie M; Kristoffersen Wiberg M; Kaijser M; Forsgard N; Zetterberg H; Wahlund LO; Shams S
J Alzheimers Dis; 2020; 78(3):1229-1236. PubMed ID: 33104030
[TBL] [Abstract][Full Text] [Related]
24. Dissection of genotype-phenotype associations in rice grains using metabolome quantitative trait loci analysis.
Matsuda F; Okazaki Y; Oikawa A; Kusano M; Nakabayashi R; Kikuchi J; Yonemaru J; Ebana K; Yano M; Saito K
Plant J; 2012 May; 70(4):624-36. PubMed ID: 22229385
[TBL] [Abstract][Full Text] [Related]
25. Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders.
Yang C; Farias FHG; Ibanez L; Suhy A; Sadler B; Fernandez MV; Wang F; Bradley JL; Eiffert B; Bahena JA; Budde JP; Li Z; Dube U; Sung YJ; Mihindukulasuriya KA; Morris JC; Fagan AM; Perrin RJ; Benitez BA; Rhinn H; Harari O; Cruchaga C
Nat Neurosci; 2021 Sep; 24(9):1302-1312. PubMed ID: 34239129
[TBL] [Abstract][Full Text] [Related]
26. Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts.
Zhu XC; Wang HF; Jiang T; Lu H; Tan MS; Tan CC; Tan L; Tan L; Yu JT;
Mol Neurobiol; 2017 Jan; 54(1):551-562. PubMed ID: 26742530
[TBL] [Abstract][Full Text] [Related]
27. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
[TBL] [Abstract][Full Text] [Related]
28. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
[TBL] [Abstract][Full Text] [Related]
29. Targeted metabolomic profiling of cerebrospinal fluid from patients with progressive multifocal leukoencephalopathy.
Luo Y; Möhn N; Al-Mekhlafi A; Schuchardt S; Skripuletz T; Sühs W; Pessler F; Stangel M
PLoS One; 2020; 15(11):e0242321. PubMed ID: 33232337
[TBL] [Abstract][Full Text] [Related]
30. Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
Belloy ME; Napolioni V; Han SS; Le Guen Y; Greicius MD;
JAMA Neurol; 2020 Jul; 77(7):849-862. PubMed ID: 32282020
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide association study identifies
Chen J; Yu JT; Wojta K; Wang HF; Zetterberg H; Blennow K; Yokoyama JS; Weiner MW; Kramer JH; Rosen H; Miller BL; Coppola G; Boxer AL;
Neurology; 2017 Feb; 88(7):669-676. PubMed ID: 28100725
[TBL] [Abstract][Full Text] [Related]
32. Whole-exome sequencing identifies common and rare variant metabolic QTLs in a Middle Eastern population.
Yousri NA; Fakhro KA; Robay A; Rodriguez-Flores JL; Mohney RP; Zeriri H; Odeh T; Kader SA; Aldous EK; Thareja G; Kumar M; Al-Shakaki A; Chidiac OM; Mohamoud YA; Mezey JG; Malek JA; Crystal RG; Suhre K
Nat Commun; 2018 Jan; 9(1):333. PubMed ID: 29362361
[TBL] [Abstract][Full Text] [Related]
33. Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.
Haapalinna F; Kokki M; Jääskeläinen O; Hallikainen M; Helisalmi S; Koivisto A; Kokki H; Paajanen T; Penttinen J; Pikkarainen M; Rautiainen M; Soininen H; Solje E; Remes AM; Herukka SK
J Alzheimers Dis; 2018; 62(1):165-174. PubMed ID: 29439329
[TBL] [Abstract][Full Text] [Related]
34. Cholesterol metabolites and plant sterols in cerebrospinal fluid are associated with Alzheimer's cerebral pathology and clinical disease progression.
Jahn T; Clark C; Kerksiek A; Lewczuk P; Lütjohann D; Popp J
J Steroid Biochem Mol Biol; 2021 Jan; 205():105785. PubMed ID: 33171206
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort.
Cong W; Meng X; Li J; Zhang Q; Chen F; Liu W; Wang Y; Cheng S; Yao X; Yan J; Kim S; Saykin AJ; Liang H; Shen L;
BMC Genomics; 2017 May; 18(1):421. PubMed ID: 28558704
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.
Deming Y; Li Z; Kapoor M; Harari O; Del-Aguila JL; Black K; Carrell D; Cai Y; Fernandez MV; Budde J; Ma S; Saef B; Howells B; Huang KL; Bertelsen S; Fagan AM; Holtzman DM; Morris JC; Kim S; Saykin AJ; De Jager PL; Albert M; Moghekar A; O'Brien R; Riemenschneider M; Petersen RC; Blennow K; Zetterberg H; Minthon L; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Schellenberg G; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Peskind ER; Li G; Di Narzo AF; ; ; Kauwe JS; Goate AM; Cruchaga C
Acta Neuropathol; 2017 May; 133(5):839-856. PubMed ID: 28247064
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide association study identified ATP6V1H locus influencing cerebrospinal fluid BACE activity.
Hu H; Li H; Li J; Yu J; Tan L;
BMC Med Genet; 2018 May; 19(1):75. PubMed ID: 29751835
[TBL] [Abstract][Full Text] [Related]
38. Alzheimer's disease susceptibility locus in CD2AP is associated with increased cerebrospinal fluid tau levels in mild cognitive impairment.
Xue YY; Chen YH; Lin RR; Huang HF; Wu ZY; Tao QQ;
Neurosci Lett; 2022 Feb; 771():136419. PubMed ID: 34958910
[TBL] [Abstract][Full Text] [Related]
39. Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples.
Stoop MP; Coulier L; Rosenling T; Shi S; Smolinska AM; Buydens L; Ampt K; Stingl C; Dane A; Muilwijk B; Luitwieler RL; Sillevis Smitt PA; Hintzen RQ; Bischoff R; Wijmenga SS; Hankemeier T; van Gool AJ; Luider TM
Mol Cell Proteomics; 2010 Sep; 9(9):2063-75. PubMed ID: 20811074
[TBL] [Abstract][Full Text] [Related]
40. Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort.
Elias-Sonnenschein LS; Helisalmi S; Natunen T; Hall A; Paajanen T; Herukka SK; Laitinen M; Remes AM; Koivisto AM; Mattila KM; Lehtimäki T; Verhey FR; Visser PJ; Soininen H; Hiltunen M
PLoS One; 2013; 8(4):e59676. PubMed ID: 23573206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
